Laura Falasca Selected Research

Laura Falasca Research Topics

5	Infections 06/2022 - 01/2003
5	COVID-19 06/2022 - 01/2021
2	Sepsis (Septicemia) 07/2010 - 02/2008
2	Splenomegaly 06/2005 - 06/2003
2	Glomerulonephritis 06/2005 - 06/2003
1	Angioedema 01/2022
1	Macroglossia 01/2022
1	Necrosis 03/2021
1	Hyperferritinemia 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Iron Overload 01/2021
1	Disease Progression 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Carcinogenesis 02/2016
1	Neoplasms (Cancer) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 12/2015
1	Huntington Disease (Huntington's Disease) 11/2014
1	Tuberculosis (Tuberculoses) 09/2012
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Papillomavirus Infections 06/2011
1	Melanoma (Melanoma, Malignant) 04/2011
1	Hypertension (High Blood Pressure) 10/2010
1	Insulin Resistance 10/2010
1	Acute Cholecystitis 10/2010
1	Hepatitis 10/2010
1	Endotoxemia 02/2008
1	Shock 02/2008
1	Hyperplasia 06/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2003

6	TransglutaminasesIBA 01/2021 - 06/2005
4	EnzymesIBA 01/2021 - 04/2003
3	Proteins (Proteins, Gene)FDA Link 02/2016 - 04/2003
2	Cysteamine (Mercaptamine)FDA Link 06/2022 - 12/2021
2	VaccinesIBA 06/2022 - 09/2012
2	Pharmaceutical PreparationsIBA 06/2022 - 12/2021
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021 - 01/2003
2	AutoantibodiesIBA 06/2005 - 06/2003
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	CystamineIBA 12/2021
1	CholesterolIBA 12/2021
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	CatecholaminesIBA 03/2021
1	Ferritins (Ferritin)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	IronIBA 01/2021
1	Caveolin 1IBA 01/2019
1	ChemokinesIBA 01/2018
1	Beclin-1IBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Ataxin-1IBA 06/2012
1	polyglutamineIBA 06/2012
1	Purinergic Receptors (Receptors, Purine)IBA 08/2011
1	Adenosine Triphosphate (ATP)IBA 08/2011
1	Oncogene Proteins (Oncogene Protein)IBA 06/2011
1	PolyaminesIBA 06/2011
1	FenretinideIBA 04/2011
1	Bortezomib (Velcade)FDA Link 04/2011
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2010
1	DiureticsIBA 10/2010
1	olmesartanIBA 10/2010
1	ThiazidesIBA 10/2010
1	EndotoxinsIBA 07/2010
1	NF-kappa B (NF-kB)IBA 02/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2003
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2003

5	Therapeutics 06/2022 - 10/2010